The report will be delivered in 2-3 business days.

Antidepressants Global Market Report 2020-30: Covid 19 Implications and Growth

Starting Price : $ 4000.00 | Pages : 150 | Published : April 2020 | SKU CODE : 7633 | Format :


The antidepressants market consists of sales of antidepressants and related services that are used in retail pharmacies, hospitals and clinics. Antidepressants are drugs that can help to alleviate depressive symptoms, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or moderate persistent depressive, as well as other conditions. The antidepressant medications available include the antagonists of SSRIs or selective serotonin reuptake, MAOIs or monoamine oxidase inhibitors, tricyclic antidepressants, tetracyclic antidepressants and others.

The global antidepressants market is expected to grow from $14.3 billion in 2019 to about $28.6 billion in 2020 as mental health issues are expected to surge due to the effects of the Covid-19 pandemic making an impact on the global economy. The market is expected to stabilize and reach $19 billion at a CAGR of 7.4% through 2023.

The antidepressants market has also surged during the covid-19 outbreak. The increasing number of cases and fatalities is affecting the mental health by elevating anxiety worldwide. People who are already living with mental health problems are experiencing increased stress levels over the Covid-19 outbreak. This has triggered the demand for antidepressant drugs.

The antidepressants market covered in this report is segmented by product into selective serotonin reuptake inhibitor (SSRI); serotonin-norepinephrine reuptake inhibitor (SNRI); tricyclic antidepressant (TCA); monoamine oxidase inhibitor (MAOI); other products. It is also segmented by drug class into monoamine oxidase inhibitors; serotonin antagonist and reuptake inhibitors; serotonin-norepinephrine reuptake inhibitors; selective serotonin reuptake inhibitors; tricyclic antidepressants; others and by depressive disorder into major depressive disorder; obsessive-compulsive disorder; generalized anxiety disorder; panic disorder; others.

Globally, rising cases of mental health disorders are the key factor in the growth of the antidepressant drug industry, as many customers rely on these medications to counter depression, anxiety disorder etc. Antidepressant medications are used in conditions such as depression, OCD, childhood enuresis, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), social anxiety disorder, etc. Globally, the percentage of people with depression varies from 2% to 6% and the elderly are at greater risk of depression relative to other age groups. According to WHO, in 2020, about 264 million people of all ages worldwide suffer from depression. Therefore, rising cases of mental health disorders is expected to drive the growth of the antidepressant market.

The side-effects and patent expiry of antidepressant drugs is a key factor hampering the growth of the antidepressant market. The antidepressants are Lexapro (escitalopram) and Celexa (citalopram), both of which are used to treat depression, Lexapro also helps for anxiety. Lexapro and Celexa can cause side effects common to others which includes nausea, sleeplessness, sweating, dry mouth and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures and vision issues. In 2018 the labels of the medications contained a black box warning for an increased suicide risk. Therefore, the side-effects and patent expiry of antidepressant drugs is expected to limit the growth of the antidepressant market.

The treatment for resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviours. In 2018, Food and Drug Administration (FDA) approved ketamine, an anesthetic that has made waves for its surprising antidepressant effect. Since treatment with esketamine may be of great benefit to patients with treatment-resistant depression (meaning conventional therapies have not benefited them), the FDA has speeded up the approval process to make it available more rapidly.

In May 2018, Allergan, an Ireland based company, focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world acquired Aptinyx for an unclosed amount. Through this acquisition Allergan gained important insights into NMDA receptor modulation as a potential therapeutic approach for depression. Aptinyx, a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.

Major players in the market are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, Sun Pharmaceuticals Pvt Ltd

The companies covered are Allergan PLC; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline PLC; H. Lundbeck AS; Johnson & Johnson; Pfizer Inc.; Merck & Co. Inc.; Sanofi; Sun Pharmaceuticals Pvt Ltd; Alkermes; Bristol Myers Squibb Company; Teva Pharmaceutical Industries; Eli Lilly and Co.; Takeda Pharmaceutical Co. Ltd; Forest laboratories; Akeda Pharmaceutical; Others

Countries covered are Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI); Serotonin-norepinephrine Reuptake Inhibitor (SNRI); Tricyclic Antidepressant (TCA); Monoamine Oxidase Inhibitor (MAOI) 2) By Drug Class: Monoamine oxidase inhibitors; Serotonin antagonist and reuptake inhibitors; Serotonin-norepinephrine reuptake inhibitors; Selective serotonin reuptake inhibitors; Tricyclic antidepressants 3) By Depressive Disorder: Major Depressive Disorder; Obsessive-Compulsive Disorder; Generalized Anxiety Disorder; Panic Disorder

    1. Executive Summary

    2. Antidepressants Market Characteristics

    3. Antidepressants Market Size And Growth

    3.1. Global Antidepressants Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Antidepressants Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Antidepressants Market Segmentation

    4.1. Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Selective Serotonin Reuptake Inhibitor (SSRI)

    Serotonin-norepinephrine Reuptake Inhibitor (SNRI)

    Tricyclic Antidepressant (TCA)

    Monoamine Oxidase Inhibitor (MAOI)

    Other Products

    4.2. Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Monoamine oxidase inhibitors

    Serotonin antagonist and reuptake inhibitors

    Serotonin-norepinephrine reuptake inhibitors

    Selective serotonin reuptake inhibitors

    Tricyclic antidepressants

    Others

    4.3. Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Major Depressive Disorder

    Obsessive-Compulsive Disorder

    Generalized Anxiety Disorder

    Panic Disorder

    Others

    5. Antidepressants Market Regional And Country Analysis

    5.1. Global Antidepressants Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Antidepressants Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Antidepressants Market  

    6.1. Asia-Pacific Antidepressants Market Overview  

    6.2. Asia-Pacific Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Antidepressants Market  

    7.1. China Antidepressants Market Overview  

    7.2. China Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Antidepressants Market  

    8.1. India Antidepressants Market Overview  

    8.2. India Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Antidepressants Market  

    9.1. Japan Antidepressants Market Overview  

    9.2. Japan Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Antidepressants Market  

    10.1. Australia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Antidepressants Market  

    11.1. Indonesia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Antidepressants Market  

    12.1. South Korea Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Antidepressants Market  

    13.1. Western Europe Antidepressants Market Overview

    13.2. Western Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Antidepressants Market  

    14.1. UK Antidepressants Market Overview

    14.2. UK Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Antidepressants Market  

    15.1. Germany Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Antidepressants Market  

    16.3. France Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Antidepressants Market  

    17.1. Eastern Europe Antidepressants Market Overview

    17.2. Eastern Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Antidepressants Market  

    18.1. Russia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Antidepressants Market  

    19.1. North America Antidepressants Market Overview

    19.2. North America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Antidepressants Market  

    20.1. USA Antidepressants Market Overview

    20.2. USA Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Antidepressants Market  

    21.1. South America Antidepressants Market Overview

    21.2. South America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Antidepressants Market  

    22.1. Brazil Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Antidepressants Market  

    23.1. Middle East Antidepressants Market Overview

    23.2. Middle East Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Antidepressants Market  

    24.1. Africa Antidepressants Market Overview

    24.2. Africa Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Antidepressants Market Competitive Landscape And Company Profiles

    25.1. Antidepressants Market Competitive Landscape

    25.2. Antidepressants Market Company Profiles

    25.2.1. Allergan PLC

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. AstraZeneca

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Eli Lilly and Company

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. GlaxoSmithKline PLC

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. H. Lundbeck AS

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Antidepressants Market

    27. Antidepressants Market Trends And Strategies

    28. Antidepressants Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Antidepressants Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Antidepressants Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: China, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: India, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Japan, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: Australia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Indonesia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: South Korea, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Western Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: UK, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Germany, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: France, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Eastern Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: Russia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: North America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: USA, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: South America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Brazil, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Middle East, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Africa, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: Allergan PLC Financial Performance
  • Table 28: AstraZeneca Financial Performance
  • Table 29: Eli Lilly and Company Financial Performance
  • Table 30: GlaxoSmithKline PLC Financial Performance
  • Table 31: H. Lundbeck AS Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Antidepressants Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global Antidepressants Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: China, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: India, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Japan, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: Australia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: Indonesia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: South Korea, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Western Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: UK, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Germany, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: France, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Eastern Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: Russia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: North America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: USA, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: South America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Brazil, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Middle East, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Africa, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: Allergan PLC Financial Performance
  • Figure 28: AstraZeneca Financial Performance
  • Figure 29: Eli Lilly and Company Financial Performance
  • Figure 30: GlaxoSmithKline PLC Financial Performance
  • Figure 31: H. Lundbeck AS Financial Performance
Demand For Corticosteroids Therapy Has Grown Due To Positive Outcomes In Treatment Of Covid-19
The Respiratory Devices Market Will See Significant Growth As Covid-19 Cases Rise
The N95 And Surgical Masks Market Is Experiencing An Exponential Growth Due To The Covid-19 Pandemic
Asia Pacific Was The Largest Region Accounting For 37% Of The Global Diagnostic Imaging Centers Market
The Microneedle Drug Delivery System Is Gaining Popularity In The Drug Delivery Devices Market
Use Of Combination Drugs For Antiretroviral Therapy In The HIV Drugs Market
Rapidly Aging Population Will Significantly Affect The Retirement Communities Market Growth
Adoption Of Cognitive Behavioral Therapy And Applied Behavioral Analysis In The Psychiatrists’ Market
Robotic Surgery Services Market Global Report 2020-30: Covid 19 Growth and Change
View Report
Retirement Communities Market Segmentation (Continuing Care Retirement Communities, Rest Homes, Assisted Living Facilities, Assisted Living Facilities With Nursing Care) By Trends, Customer Information, Drivers and Restraints - Global Forecasts To 2023
View Report
Psychiatrists Market By Segmentation (Mental Disorder Type, Patient Type, Geography), By Trends, By Restraints, By Drivers, By Major Competitors - Global Forecasts to 2023
View Report
Residential Substance Abuse And Mental Health Facilities Market Global Briefing 2018
View Report
Home Health Care Providers Global Market Report 2018
View Report
Diagnostic Imaging Centers Global Market Report 2018
View Report
Home Health Care And Residential Nursing Care Services Global Market Report 2018
View Report
Family Planning Centers Global Market Report 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)